Dr. Freilich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6675 Holmes Rd Ste 430
Kansas City, MO 64131Phone+1 816-361-0055Fax+1 816-361-5775- Is this information wrong?
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1991 - 1994
- Rush University Medical CenterResidency, Internal Medicine, 1988 - 1991
- University of Missouri Kansas City School of MedicineClass of 1988
Certifications & Licensure
- CA State Medical License 1991 - Present
- KS State Medical License 1994 - 2024
- MO State Medical License 1994 - 2024
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
- Fellow (AGAF) American Gastroenterological Association, 2006
Clinical Trials
- Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis Start of enrollment: 2014 Mar 27
- Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis Start of enrollment: 2014 Apr 01
- Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for Testing Start of enrollment: 2014 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsA randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis.Stephen A Harrison, Peter J Ruane, Bradley Freilich, Guy Neff, Rashmee Patil, Cynthia Behling, Chen Hu, Reshma Shringarpure, Brittany de Temple, Erica Fong, Erik J Til...> ;JHEP Reports. 2023 Jan 1
- 15 citationsAldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial.Stephen A Harrison, Manal F Abdelmalek, Guy Neff, Nadege Gunn, Cynthia D Guy, Naim Alkhouri, Mustafa R Bashir, Bradley Freilich, Anita Kohli, Arun Khazanchi, Muhammad ...> ;The Lancet. Gastroenterology & Hepatology. 2022 Jul 1
- 7 citationsRedefinition of Fatty Liver Disease from NAFLD to MAFLD through the Lens of Drug Development and Regulatory Science.Yasser Fouad, Melissa Palmer, Minjun Chen, Arie Regev, Rajarshi Banerjee, Rob Myers, Robert Riccio, Richard Torstenson, Ramy Younes, Puneet S Arora, Henrik Landgren, M...> ;Journal of Clinical and Translational Hepatology. 2022 Apr 28
- Join now to see all
Professional Memberships
- Fellow
- Member
Hospital Affiliations
- Cameron Regional Medical CenterCameron, Missouri
- Research Medical CenterKansas City, Missouri
- Menorah Medical CenterLeawood, Kansas
- Overland Park Regional Medical CenterLenexa, Kansas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: